TargetBeta
GRIN1
glutamate ionotropic receptor NMDA type subunit 1 · also GluN1, NR1, NMDAR1 · Glutamate ionotropic receptor NMDA type subunits
3 programs in company-led studies act on GRIN1, from 3 companies: 1 in phase 3, 2 approved with new studies. Each with where its target was read from.
Programs
Furthest phase first. A target read by rule is marked rule (3 of them); the others are the company’s own words or a reading by Claude, each quoted on the program’s page.
| Program | Company | Furthest phase | Studies | Also acts on | Read from |
|---|---|---|---|---|---|
| Esketaminerule | Johnson & Johnson | phase 4 | 512 running | GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B | ChEMBL |
| Memantinerule | AbbVie | phase 4 | 290 running | GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B | ChEMBL |
| radiprodilrule | GRIN Therapeutics | phase 3 | 94 running | GRIN2B | ChEMBL |
Conditions their studies are in
- Alzheimer Disease, 1 program
- Autism Spectrum Disorder, 1 program
- Autistic Disorder, 1 program
- Cancer Pain, 1 program
- Depression, 1 program
- Depressive Disorder, Major, 1 program
- Depressive Disorder, Treatment-Resistant, 1 program
- Glaucoma, Open-Angle, 1 program
- Neurodevelopmental Disorders, 1 program
- Pain, 1 program
Primary completions ahead
Each program’s next study to reach its primary completion, by the sponsor’s estimate.
- Nov 2026radiprodil · GRIN Therapeutics · phase 3 · NCT05818943
- Dec 27, 2028Esketamine · Johnson & Johnson · phase 4 · NCT07716098
What this can’t show
- Only programs whose target has been read: most early programs are named only by a code and their companies do not say what they act on.
- A target read by rule can be wrong; each program’s page quotes the words it was read from.
- “Acts on” does not say how: an agonist and an antagonist of the same receptor are listed together (avexitide blocks the GLP-1 receptor that semaglutide activates).
- Programs in company-led studies on ClinicalTrials.gov with a study in the last two years; academic studies and other registries are not counted here.